Health Benefits of Whole-body Vibration
VIBE-Rx
Pilot Investigation on the Health Benefits of Sub Acute (12 Week) Whole-body Vibration Training
1 other identifier
interventional
40
1 country
1
Brief Summary
The overall goals of this pilot investigation are to determine 1) the feasibility of conducting home based WBV studies, and 2) to determine if sub-acute home based WBV can improve a) exercise capacity, b) conduit- and micro- vascular function, and c) skeletal muscle function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
October 28, 2021
CompletedStudy Start
First participant enrolled
February 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
January 28, 2025
January 1, 2025
4.8 years
October 15, 2021
January 27, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Change in VO2 Peak
change from baseline relative (mL/kg/min) peak oxygen consumption (VO2) during maximal exercise test at 12 weeks
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Change in Flow-Mediated Dilation (FMD)
change from baseline brachial artery flow mediated dilation at 12 weeks.
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Change in Skeletal Muscle Mitochondrial Function
change from baseline skeletal muscle mitochondrial function at 12 weeks. Measured using Near Infrared Spectroscopy (NIRS). Values are an index of phosphocreatine recovery expressed as a rate constant (min-1)
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Change in Pulse Wave Velocity (PWV)
Change from baseline PWV at 12 weeks. Measured by Shygmocor Xcel in m/s.
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Change in Post Occlusive Reactive Hyperemia (PORH)
Change from baseline PORH at 12 weeks. Measured by Laser Speckle Contrast Imager (Moor FLPI).
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Change in IL-6
change from baseline concentrations of Interleukin 6 (IL-6) obtained via blood draw at 12 weeks.
pre-treatment baseline and following 12 weeks sub-acute whole-body vibration
Study Arms (1)
Sub Acute (12 week) Whole Body Training
EXPERIMENTALInterventions
Participants will be given a personal vibration plate to take home with them for training which will last for 12 weeks. For the first four weeks, participants will be asked to complete 10 minutes of WBV per day (1 minute on and up to 1 minute of rest), at least 3-4 days per week. At least 24 hours will be recommended in between sessions during weeks 1-4. Beginning at week 5, participants will be asked to increase WBV time to up to 14 minutes and/or reduce the duration of rest. Beginning at week 9, participants will be asked to increase WBV time to up to 20 minutes and/or reduce the duration of rest.
Eligibility Criteria
You may qualify if:
- Men and women (\> 18 yrs old)
- All races
You may not qualify if:
- \<18 years old
- Clinical diagnosis of hepatic, cardiovascular, or renal disease
- Diabetic complications (i.e. macrovascular, microvascular, or autonomic)
- Pregnancy
- Direct vasoactive medications (i.e. nitrates)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology
Augusta, Georgia, 30912, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 15, 2021
First Posted
October 28, 2021
Study Start
February 28, 2022
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
January 28, 2025
Record last verified: 2025-01